Posted on 23 sept. 22 Sep 2013 Vienna, (EFE).- AGENCIA EFE – Language: Spanish
It has been presented today during the World Congress of Neurology in Vienna the study that relates the majority of cases of migraine with the shortage of the enzyme that metabolizes the molecule histamine. This finding opens the door to the preventive treatment using a dietary intake with the enzyme diamine oxidase (DAO). The research, developed by a team of the Hospital General of Catalonia, analyzed the response of two groups of patients with chronic migraine: one supplied with a contribution of the enzyme diamine oxidase (DAO), while another was simply a placebo.“It has been shown that the people who took the diamino oxidase enzyme supplementation, the difference, the improvement, was significantly different from those who took placebo, which confirms that a diet with a DAO supplementation had a greater effectiveness than a simple placebo,” explained today to Efe The neurologist Joan Izquierdo, director of the research.
